Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001415889-25-016764
Filing Date
2025-06-11
Accepted
2025-06-11 19:51:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 15850
  Complete submission text file 0001415889-25-016764.txt   17649
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo BioPharma Group plc (Subject) CIK: 0001719714 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-91444 | Film No.: 251041291
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 7500 OLD GEORGETOWN ROAD SUITE 800 BETHESDA MD 20814
Business Address 7500 OLD GEORGETOWN ROAD SUITE 800 BETHESDA MD 20814 240-800-1200
Northpond Ventures, LP (Filed by) CIK: 0001867472 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: SCHEDULE 13G